AI Plus

China's 'AI Plus' initiative is a national priority focused on advancing artificial intelligence across various sectors. It's newsworthy due to recent emphasis in China's 15th five-year plan, highlighting the 'safe and orderly' development of AI amid global concerns about its disruptive potential. Recent developments include the groundbreaking of a major data center in Hong Kong's Northern Metropolis, designed to boost computing power for AI development. Furthermore, pharmaceutical executives predict China could approve the first fully AI-designed drug as early as 2026. This initiative signifies China's commitment to becoming a leader in AI, with a focus on both technological advancement and responsible implementation, impacting industries from technology infrastructure to pharmaceuticals.